๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Cohance Lifesciences Limited (BOM:543064)
India flag India ยท Delayed Price ยท Currency is INR
462.00
+2.85 (0.62%)
At close: Nov 20, 2026

Cohance Lifesciences Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
20,62622,68626,08510,51413,40313,202
Revenue Growth
70.38%-13.03%148.11%-21.56%1.52%30.75%
Gross Profit
12,88214,64316,6556,7977,5217,461
Operating Income
343.52,4136,6063,5445,2625,416
Net Income
473.71,7924,8733,0034,1134,538
Earnings Per Share
1.234.6812.6811.8016.1617.83
EPS Growth
-82.13%-63.10%7.53%-26.99%-9.37%25.27%

Revenue by Geography

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period EndingMar '26 Mar '25 Mar '24 Mar '23
USA
6,7256,3511,477833.9
Europe
7,21910,9447,36211,618
India
3,1713,491964.4259.34
Rest of The World
5,2914,802536.5600.13
Total
22,40725,58810,34113,311

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
2,9293,2012,9798,2114,8375,258
Total Debt
4,4844,0054,859650.1703.41971.27
Net Cash (Debt)
-1,555-803.7-1,8817,5614,1344,287
Net Cash Growth
---82.90%-3.56%858.10%
Net Cash Per Share
-4.04-2.10-4.9029.7016.2416.84

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
2,9523,6836,7343,8484,5723,300
Capital Expenditures
-2,382-2,199-3,168-518.8-2,859-751.87
Free Cash Flow
570.61,4843,5663,3291,7132,548
Free Cash Flow Growth
-58.23%-58.37%7.11%94.35%-32.78%-6.21%

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
62.46%64.55%63.85%64.65%56.11%56.51%
Operating Margin
1.67%10.64%25.33%33.71%39.26%41.02%
Pretax Margin
0.33%9.13%24.64%38.59%41.76%50.57%
Profit Margin
2.30%7.90%18.68%28.56%30.69%34.37%
FCF Margin
2.77%6.54%13.67%31.66%12.78%19.30%

Dividends

Fiscal Year
FY 2023FY 2022
Period EndingMar '23 Mar '22
Dividend Per Share
3.0002.000
Dividend Per Share Growth
50.00%0%
Dividend Yield
0.64%0.32%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
375.8164.3560.1257.4029.2434.69
P/FCF Ratio
309.9877.6982.1851.7870.2161.79
PS Ratio
8.585.0811.2316.408.9711.93